Equity Overview
Price & Market Data
Price: $7.33
Daily Change: +$0.16 / 2.18%
Daily Range: $7.26 - $7.35
Market Cap: $566,791,296
Daily Volume: 11,887
Performance Metrics
1 Week: 9.13%
1 Month: 10.99%
3 Months: -41.18%
6 Months: -36.77%
1 Year: 18.12%
YTD: -38.35%
Company Details
Employees: 191
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.